Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.

ABSTRACT:

Background and aim

A novel coronavirus severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) caused pneumonia, Coronavirus Disease 2019 (COVID-19), broke out in Wuhan, China in December 2019, and spread all over the world. Patients with COVID-19 showed huge differences in the hospital stay, progression, and prognosis. As reported, the comorbidities may play an important role in COVID-19. Here, we aim to address the role of cardiovascular disease (CVD) in the progression and prognosis of COVID-19.

Methods and results

Eighty-three confirmed COVID-19 patients were divided into CVD (n = 42) and non-CVD (n = 41) group according to their medical history. Medical records including demographic data, medical history, clinical characteristics, laboratory examinations, chest co

SUBMITTER: Li M 

PROVIDER: S-EPMC7165120 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature